Literature DB >> 10488813

Brain choline acetyltransferase and mental function in Alzheimer disease.

D S Baskin1, J L Browning, F J Pirozzolo, S Korporaal, J A Baskin, S H Appel.   

Abstract

OBJECTIVE: To determine whether higher brain levels of choline acetyltransferase (ChAT) are associated with improved neuropsychological function in patients with Alzheimer disease (AD).
DESIGN: Case series with single-blind post hoc analysis of biopsy specimens.
SETTING: Urban hospital and medical school. PATIENTS: A consecutive sample of 8 patients with AD undergoing brain biopsy and surgical implantation of intraventricular pumps for administration of potential chemotherapeutic agents.
INTERVENTIONS: Brain biopsy, surgical implantation of intraventricular pumps, and, in 1 patient, ventriculoperitoneal shunt placement. MAIN OUTCOME MEASURES: All patients underwent neuropsychological testing no more than 2 weeks before surgical biopsy. Levels of ChAT were determined in fresh brain tissue from biopsy samples.
RESULTS: Significant positive correlations were found between ChAT levels and 2 neuropsychological test scores, Mini-Mental State Examination and the Logical Memory subtest of the Wechsler Memory Scale.
CONCLUSION: Degeneration of the cholinergic system in vivo correlates with decreasing cognitive function in patients with AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488813     DOI: 10.1001/archneur.56.9.1121

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

Review 1.  Neurotrophic natural products: chemistry and biology.

Authors:  Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2013-12-18       Impact factor: 15.336

2.  Regional acetylcholinesterase activity and its correlation with behavioral performances in 15-month old transgenic mice expressing the human C99 fragment of APP.

Authors:  M Dumont; R Lalonde; J-F Ghersi-Egea; K Fukuchi; C Strazielle
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

Review 3.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

4.  Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).

Authors:  Xia Shao; Raphaël Hoareau; Brian G Hockley; Louis J M Tluczek; Bradford D Henderson; Henry C Padgett; Peter J H Scott
Journal:  J Labelled Comp Radiopharm       Date:  2011-05-30       Impact factor: 1.921

Review 5.  Cholinesterase inhibitors for Alzheimer's disease.

Authors:  J Grutzendler; J C Morris
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease.

Authors:  Michel Grothe; Laszlo Zaborszky; Mercedes Atienza; Eulogio Gil-Neciga; Rafael Rodriguez-Romero; Stefan J Teipel; Katrin Amunts; Aida Suarez-Gonzalez; Jose L Cantero
Journal:  Cereb Cortex       Date:  2009-11-04       Impact factor: 5.357

Review 7.  Intrathecal pumps.

Authors:  Shawn Belverud; Alon Mogilner; Michael Schulder
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

8.  Transplantation of NGF-gene-modified bone marrow stromal cells into a rat model of Alzheimer' disease.

Authors:  Li-Yan Li; Jin-Tao Li; Qing-Ying Wu; Jin Li; Zhong-Tang Feng; Su Liu; Ting-Hua Wang
Journal:  J Mol Neurosci       Date:  2007-12-12       Impact factor: 3.444

9.  Synthesis and in vitro evaluation of novel nortropane derivatives as potential radiotracers for muscarinic m(2) receptors.

Authors:  Remco J J Knol; Jan C van den Bos; Anton G M Janssen; Kora de Bruin; Berthe L F van Eck-Smit; Jan Booij
Journal:  Int J Mol Imaging       Date:  2011-06-13

10.  Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients.

Authors:  Grace McMacken; Roger G Whittaker; Teresinha Evangelista; Angela Abicht; Marina Dusl; Hanns Lochmüller
Journal:  J Neurol       Date:  2017-11-30       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.